secwatch.observer — SEC 8-K summary
======================================

Issuer:     OnKure Therapeutics, Inc. (OKUR)
CIK:        0001637715
Form:       8-K
Filed at:   2023-06-07T23:59:59+00:00
Accession:  0000950170-23-026807
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Reneo shareholders elect three Class III directors, ratify auditor at 2023 annual meeting
--------------------------------------------------------------------------------

- Elected all three Class III director nominees: Mathers 15.75M for, Muralidhar 15.42M for, Seltzer 15.94M for; 3.76M broker non-votes each.
- Ratified Ernst & Young as independent auditor for FY2023 with 20.32M votes for, 12.6K against, 100 abstain.
- Record date April 10, 2023; 25,107,430 shares outstanding entitled to vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1637715/000095017023026807/0000950170-23-026807-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1637715/000095017023026807/rphm-20230606.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-026807

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer